Search

everythinglearnresearchcommunity

for

Search:↓

Noni fruit extract, specifically the FEA-3 sub-fraction, can increase hair growth and reduce baldness in male rabbits, potentially acting like common hair loss treatments.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Meloside A may help protect hair cells from damage linked to hair loss.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Androgens may improve pig reproduction by enhancing ovulation and litter size.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Higher levels of heat shock protein 27 and lower levels of miR-1 can increase AR levels, leading to hair loss in men.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

A point mutation in the androgen receptor gene causes complete androgen insensitivity.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Clascoterone may be an effective topical treatment for hair loss.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

New compounds were made that are promising for prostate cancer therapy.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

AKR1C enzymes in scalp glands decrease with age, possibly affecting hair loss.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

AH-001 could be a safer and more effective treatment for hair loss.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Dihydrotestosterone increases arterial stiffness in female mice without changing blood pressure or aortic wall thickness.